In silico study identifies peptide inhibitors that negate the effect of non-synonymous mutations in major drug targets of SARS-CoV-2 variants

Roshny PrasadBioinformatics Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, IndiaView further author information

Harikrishnan AjithBioinformatics Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, IndiaView further author information

Naveen Kumar ChandrakumaranBioinformatics Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, IndiaView further author information

Pawan Dnyaneshwar KhangarBioinformatics Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, IndiaView further author information

Anand MohanBioinformatics Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, IndiaView further author information

Shijulal Nelson-SathiBioinformatics Laboratory, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, IndiaCorrespondence[email protected]

https://orcid.org/0000-0002-3346-0383 View further author information

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Roshny Prasad, Anil Kadam, Vinitha Vinod Padippurackal, Aparna Pulikuttymadom Balasubramanian, Naveen Kumar Chandrakumaran, Kartik Suresh Rangari, Pawan Dnyaneshwar Khangar, Harikrishnan Ajith, Kathiresan Natarajan, Rajesh Chandramohanadas & Shijulal Nelson-Sathi. Discovery of small molecule entry inhibitors targeting the linoleic acid binding pocket of SARS-CoV-2 spike protein. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-15.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

In silico study identifies peptide inhibitors that negate the effect of non-synonymous mutations in major drug targets of SARS-CoV-2 variants

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

In silico study identifies peptide inhibitors that negate the effect of non-synonymous mutations in major drug targets of SARS-CoV-2 variants

Citations (1)

Read on this site (1)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date